课题基金 / 基金详情

项目摘要

项目成果

AIMIN LIU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Congenital Lung Malformation (CLM) is a series of rare birth defects that in the most severe case are fatal at birth. The effective prevention and early intervention of these defects require a comprehensive understanding of the mechanisms underlying the morphogenesis of the embryonic lungs. The PI found that mouse embryos mutant for the CPLANE (cilia and planar polarity effector) protein Intu exhibited severe defects in the growth and airway branching of the embryonic lungs. The PI will test the hypothesis that loss of Intu leads to severe loss of cilia formation, hence compromised cilia- dependent Hh and PDGF signaling. He will examine whether loss of Intu affects Hh and PDGF pathway outputs in vivo and the response of the lung tissue to Shh and PDGF in culture. He will also test the genetic interaction between Intu and a key regulator of Hh pathway, Gli2, in lung morphogenesis. Subsequently, He will examine the impact of Intu mutation on signaling pathways and tissue patterning in embryonic lung development through a candidate gene approach, in which known regulators of lung development will be examined. He will subsequently examine whether Intu mutation alters the proliferation and programmed cell death in lung development. Finally, the PI will take a transcriptomics approach, to compare the transcriptional profiles between wild type and Intu mutant lungs. The proposed research will reveal the roles of CPLANE proteins and cilia in embryonic lung development, and contribute to the better understanding of lung diseases such as CLM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The roles of Inturned in mammalian lung development
Analysis of Flexo/lft88, a novel regulator of Hh pathway
  • 批准号:
    6943369
  • 项目类别:
  • 资助金额:
    $2.97万
  • 财政年份:
    2004
  • 负责人:
    AIMIN LIU
  • 依托单位:
Analysis of Flexo/lft88, a novel regulator of Hh pathway
  • 批准号:
    6877042
  • 项目类别:
  • 资助金额:
    $4.38万
  • 财政年份:
    2004
  • 负责人:
    AIMIN LIU
  • 依托单位:
Analysis of Flexo/lft88, a novel regulator of Hh pathway
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: